A new review paper in Nicotine and Tobacco Research, finds that while research has previously found that vaping is associated with subsequently quitting smoking, that may not always be true. In fact, it appears studies limited ...
30 minutes ago
0
0
Respiratory syncytial virus (RSV), mostly infects the lungs, nose, throat, and respiratory tract, and can cause illness ranging from mild cold and fever-like symptoms to severe pneumonia and bronchitis. A recent study has ...
Partial meniscectomy does not improve patient symptoms or function, reveals a 10-year follow-up of the FIDELITY, a placebo-surgery controlled trial published in the New England Journal of Medicine.
7 hours ago
0
1
A first-of-its-kind pilot program in Utah developed by a health-technology startup company uses artificial intelligence to automatically renew certain prescriptions for patients with chronic conditions such as hypertension ...
8 hours ago
0
3
A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signaling pathway as a "door ...
9 hours ago
0
4
Car crashes, sports injuries, bad falls, severe burns and other sources of trauma can leave lasting scars in the minds of children and teens.
1 hour ago
0
0
Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from the body—by using red blood cells to deliver genetic instructions. Current CAR (chimeric antigen receptor) ...
A study conducted on an animal model by researchers at the Federal University of São Paulo (UNIFESP) in Brazil demonstrated that swimming is more effective than running in promoting healthy heart growth and improving the ...
9 hours ago
0
2
Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this type of cancer is often resistant to available treatments is that it is characterized by a highly diverse ...
At the moment, an influenza vaccine called FluMist is the only licensed intranasal vaccine approved for use in humans. The vaccine is administered through a spray of fluid in the nose, rather than with an injection.
10 hours ago
0
3
